1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > United States Orphan Drugs Industry 2015 Market Research Report

United States Orphan Drugs Industry 2015 Market Research Report

  • November 2015
  • -
  • QY Research Group
  • -
  • 131 pages

Summary


The United States Orphan Drugs Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Orphan Drugs industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Orphan Drugs market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Orphan Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 152 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

United States Orphan Drugs Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Orphan Drugs
1.2 Classification of Orphan Drugs
1.3 Applications of Orphan Drugs
1.4 Industry Chain Structure of Orphan Drugs
1.5 Industry Overview of Orphan Drugs
1.6 Industry Policy Analysis of Orphan Drugs
1.7 Industry News Analysis of Orphan Drugs

2 Manufacturing Cost Structure Analysis of Orphan Drugs
2.1 Bill of Materials (BOM) of Orphan Drugs
2.2 BOM Price Analysis of Orphan Drugs
2.3 Labor Cost Analysis of Orphan Drugs
2.4 Depreciation Cost Analysis of Orphan Drugs
2.5 Manufacturing Cost Structure Analysis of Orphan Drugs
2.6 Manufacturing Process Analysis of Orphan Drugs
2.7 China Price, Cost and Gross of Orphan Drugs 2010-2015

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Orphan Drugs Manufacturers in 2014
3.3 RandD Status and Technology Source of United States Orphan Drugs Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Orphan Drugs Key Manufacturers in 2014

4 Production Analysis of Orphan Drugs by Regions, Type, and Applications
4.1 United States Production of Orphan Drugs by Regions 2010-2015
4.2 United States Production of Orphan Drugs by Type 2010-2015
4.3 United States Sales of Orphan Drugs by Applications 2010-2015
4.4 Price Analysis of United States Orphan Drugs Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Orphan Drugs 2010-2015

5 Consumption Volume and Consumption Value Analysis of Orphan Drugs by Regions
5.1 United States Consumption Volume of Orphan Drugs by Regions 2010-2015
5.2 United States Consumption Value of Orphan Drugs by Regions 2010-2015
5.3 United States Consumption Price Analysis of Orphan Drugs by Regions 2010-2015

6 Analysis of Orphan Drugs Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Orphan Drugs 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Orphan Drugs 2014-2015
6.3 Sales Overview of Orphan Drugs 2010-2015
6.4 Supply, Consumption and Gap of Orphan Drugs 2010-2015
6.5 Import, Export and Consumption of Orphan Drugs 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Orphan Drugs 2010-2015

7 Analysis of Orphan Drugs Industry Key Manufacturers
7.1 Novartis
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Novartis SWOT Analysis

7.2 Roche
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Roche SWOT Analysis

7.3 Celgene
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Celgene SWOT Analysis

7.4 Pfizer
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Pfizer SWOT Analysis

7.5 Sanofi
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Sanofi SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Orphan Drugs Product Types
8.5 Market Share Analysis of Different Orphan Drugs Price Levels
8.6 Gross Margin Analysis of Different Orphan Drugs Applications

9 Marketing Trader or Distributor Analysis of Orphan Drugs
9.1 Marketing Channels Status of Orphan Drugs
9.2 Traders or Distributors of Orphan Drugs with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Orphan Drugs
9.4 United States Import, Export and Trade Analysis of Orphan Drugs

10 Development Trend of Orphan Drugs Industry 2016-2021
10.1 Capacity and Production Overview of Orphan Drugs 2016-2021
10.2 Production Market Share by Product Types of Orphan Drugs 2016-2021
10.3 Sales and Sales Revenue Overview of Orphan Drugs 2016-2021
10.4 United States Sales of Orphan Drugs by Applications 2016-2021
10.5 Import, Export and Consumption of Orphan Drugs 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Orphan Drugs 2016-2021

11 Industry Chain Suppliers of Orphan Drugs with Contact Information
11.1 Major Raw Materials Suppliers of Orphan Drugs with Contact Information
11.2 Manufacturing Equipment Suppliers of Orphan Drugs with Contact Information
11.3 Major Players of Orphan Drugs with Contact Information
11.4 Key Consumers of Orphan Drugs with Contact Information
11.5 Supply Chain Relationship Analysis of Orphan Drugs

12 New Project Investment Feasibility Analysis of Orphan Drugs
12.1 New Project SWOT Analysis of Orphan Drugs
12.2 New Project Investment Feasibility Analysis of Orphan Drugs

13 Conclusion of the United States Orphan Drugs Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Orphan Drugs
Table Product Specifications of Orphan Drugs
Table Classification of Orphan Drugs
Figure United States Sales Market Share of Orphan Drugs by Product Types in 2014
Table Applications of Orphan Drugs
Figure United States Sales Market Share of Orphan Drugs by Applications in 2014
Figure Industry Chain Structure of Orphan Drugs
Table United States Industry Overview of Orphan Drugs
Table Industry Policy of Orphan Drugs
Table Industry News List of Orphan Drugs
Table Bill of Materials (BOM) of Orphan Drugs
Table Bill of Materials (BOM) Price of Orphan Drugs
Table Labor Cost of Orphan Drugs
Table Depreciation Cost of Orphan Drugs
Table Manufacturing Cost Structure Analysis of Orphan Drugs in 2014
Figure Manufacturing Process Analysis of Orphan Drugs
Table United States Price Analysis of Orphan Drugs 2010-2015 (USD/Dose)
Table United States Cost Analysis of Orphan Drugs 2010-2015 (USD/Dose)
Table United States Gross Analysis of Orphan Drugs 2010-2015
Table Capacity (Doses) and Commercial Production Date of United States Orphan Drugs Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Orphan Drugs Manufacturers in 2014
Table RandD Status and Technology Source of United States Orphan Drugs Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Orphan Drugs Key Manufacturers in 2014
Table United States Production of Orphan Drugs by Regions 2010-2015 (Doses)
Table United States Production Market Share of Orphan Drugs by Regions 2010-2015
Figure United States Production Market Share of Orphan Drugs by Regions in 2014
Figure United States Production Market Share of Orphan Drugs by Regions in 2015
Table United States Production of Orphan Drugs by Types in 2010-2015 (Doses)
Table United States Production Market Share of Orphan Drugs by Type in 2010-2015
Figure United States Production Market Share of Orphan Drugs by Type in 2014
Figure United States Production Market Share of Orphan Drugs by Type in 2015
Table United States Sales of Orphan Drugs by Applications 2010-2015 (Doses)
Table United States Production Market Share of Orphan Drugs by Applications 2010-2015
Figure United States Production Market Share of Orphan Drugs by Applications in 2014
Figure United States Production Market Share of Orphan Drugs by Applications in 2015
Table Price Comparison of United States Orphan Drugs Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Orphan Drugs 2010-2015
Table United States Consumption Volume of Orphan Drugs by Regions 2010-2015 (Doses)
Table United States Consumption Volume Market Share of Orphan Drugs by Regions 2010-2015 (%)
Figure United States Consumption Volume Market Share of Orphan Drugs by Regions in 2014
Figure United States Consumption Volume Market Share of Orphan Drugs by Regions in 2015
Table United States Consumption Value of Orphan Drugs by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Orphan Drugs by Regions 2010-2015
Figure United States Consumption Value Market Share of Orphan Drugs by Regions in 2014
Figure United States Consumption Value Market Share of Orphan Drugs by Regions in 2015
Table Consumption Price of Orphan Drugs by Regions 2010-2015 (USD/Dose)
Table United States and Major Manufacturers Capacity of Orphan Drugs 2010-2015 (Doses)
Table United States Capacity Market Share of Major Orphan Drugs Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Orphan Drugs 2010-2015 (Doses)
Table United States Production Market Share of Major Orphan Drugs Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Orphan Drugs 2010-2015 (Doses)
Table United States Sales Market Share of Major Orphan Drugs Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Orphan Drugs 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Orphan Drugs Manufacturers 2010-2015
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Orphan Drugs 2010-2015
Figure United States Capacity Utilization Rate of Orphan Drugs 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Orphan Drugs 2010-2015
Figure United States Production Market Share of Major Orphan Drugs Manufacturers in 2014
Figure United States Production Market Share of Major Orphan Drugs Manufacturers in 2015
Figure United States Sales Market Share of Major Orphan Drugs Manufacturers in 2014
Figure United States Sales Market Share of Major Orphan Drugs Manufacturers in 2015
Figure United States Sales (Doses) and Growth Rate of Orphan Drugs 2010-2015
Table United States Supply, Consumption and Gap of Orphan Drugs 2010-2015 (Doses)
Table United States Import, Export and Consumption of Orphan Drugs 2010-2015 (Doses)
Table Price of United States Orphan Drugs Major Manufacturers 2010-2015 (USD/Dose)
Table Gross Margin of United States Orphan Drugs Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Orphan Drugs 2010-2015 (M USD)
Table United States Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Orphan Drugs 2010-2015
Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan Drugs Picture and Specifications of Novartis
Table Orphan Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novartis 2010-2015
Figure Orphan Drugs Capacity (Doses), Production (Doses) and Growth Rate of Novartis 2010-2015
Figure Orphan Drugs Production (Doses) and United States Market Share of Novartis 2010-2015
Table Novartis Orphan Drugs SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan Drugs Picture and Specifications of Roche
Table Orphan Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2010-2015
Figure Orphan Drugs Capacity (Doses), Production (Doses) and Growth Rate of Roche 2010-2015
Figure Orphan Drugs Production (Doses) and United States Market Share of Roche 2010-2015
Table Roche Orphan Drugs SWOT Analysis
Table Celgene Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan Drugs Picture and Specifications of Celgene
Table Orphan Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Celgene 2010-2015
Figure Orphan Drugs Capacity (Doses), Production (Doses) and Growth Rate of Celgene 2010-2015
Figure Orphan Drugs Production (Doses) and United States Market Share of Celgene 2010-2015
Table Celgene Orphan Drugs SWOT Analysis
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan Drugs Picture and Specifications of Pfizer
Table Orphan Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2010-2015
Figure Orphan Drugs Capacity (Doses), Production (Doses) and Growth Rate of Pfizer 2010-2015
Figure Orphan Drugs Production (Doses) and United States Market Share of Pfizer 2010-2015
Table Pfizer Orphan Drugs SWOT Analysis
Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan Drugs Picture and Specifications of Sanofi
Table Orphan Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sanofi 2010-2015
Figure Orphan Drugs Capacity (Doses), Production (Doses) and Growth Rate of Sanofi 2010-2015
Figure Orphan Drugs Production (Doses) and United States Market Share of Sanofi 2010-2015
Table Sanofi Orphan Drugs SWOT Analysis
Table Orphan Drugs Price by Regions 2010-2015
Table Orphan Drugs Price by Product Types 2010-2015
Table Orphan Drugs Price by Companies 2010-2015
Table Orphan Drugs Gross Margin by Companies 2010-2015
Table Price Comparison of Orphan Drugs by Regions 2010-2015 (USD/Dose)
Table Price of Different Orphan Drugs Product Types (USD/Dose)
Table Market Share of Different Orphan Drugs Price Level
Table Gross Margin of Different Orphan Drugs Applications
Table Marketing Channels Status of Orphan Drugs
Table Traders or Distributors of Orphan Drugs with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Orphan Drugs (USD/Dose) in 2015
Table United States Import, Export, and Trade of Orphan Drugs (Doses)
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Orphan Drugs 2016-2021
Figure United States Capacity Utilization Rate of Orphan Drugs 2016-2021
Table United States Orphan Drugs Production by Type 2016-2021 (Doses)
Table United States Orphan Drugs Production Market Share by Type 2016-2021
Figure United States Production Market Share of Orphan Drugs by Type in 2021
Figure United States Sales (Doses) and Growth Rate of Orphan Drugs 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Orphan Drugs 2016-2021
Figure United States Sales of Orphan Drugs by Applications 2016-2021 (Doses)
Table United States Production Market Share of Orphan Drugs by Applications 2016-2021
Figure United States Production Market Share of Orphan Drugs by Applications in 2021
Table United States Production, Import, Export and Consumption of Orphan Drugs 2016-2021 (Doses)
Table United States Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Orphan Drugs 2016-2021
Table Major Raw Materials Suppliers of Orphan Drugs with Contact Information
Table Manufacturing Equipment Suppliers of Orphan Drugs with Contact Information
Table Major Players of Orphan Drugs with Contact Information
Table Key Consumers of Orphan Drugs with Contact Information
Table Supply Chain Relationship Analysis of Orphan Drugs
Table New Project SWOT Analysis of Orphan Drugs
Table New Project Investment Feasibility Analysis of Orphan Drugs
Table Part of Interviewees Record List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Opioid Market in the US

  • December 2016
    14 pages
  • Opioid  

  • United States  

View report >

Therapy Market in Denmark - Forecast

  • December 2016
    12 pages
  • Therapy  

  • Denmark  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.